Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Head and Neck Cancer

  Free Subscription

Articles published in Int J Cancer

Retrieve available abstracts of 84 articles:
HTML format

Single Articles

    August 2022
  1. LIU Y, Zheng Z, Li M, Zhang Y, et al
    Comparison of concurrent chemoradiotherapy with radiotherapy alone for locally advanced esophageal squamous cell cancer in elderly patients: A randomized, multicenter, phase II clinical trial.
    Int J Cancer. 2022;151:607-615.
    PubMed     Abstract available

  2. TIAN Y, Tang C, Shi G, Wang G, et al
    Novel fluorescent GLUT1 inhibitor for precision detection and fluorescence image-guided surgery in oral squamous cell carcinoma.
    Int J Cancer. 2022;151:450-462.
    PubMed     Abstract available

    June 2022
  3. WANG S, Zheng R, Arnold M, Abnet C, et al
    Global and national trends in the age-specific sex ratio of esophageal cancer and gastric cancer by subtype.
    Int J Cancer. 2022 Jun 9. doi: 10.1002/ijc.34158.
    PubMed     Abstract available

    May 2022
  4. IM PK, Yang L, Kartsonaki C, Chen Y, et al
    Alcohol metabolism genes and risks of site-specific cancers in Chinese adults: An 11-year prospective study.
    Int J Cancer. 2022;150:1627-1639.
    PubMed     Abstract available

    April 2022
  5. LAAKSONEN MA, MacInnis RJ, Canfell K, Shaw JE, et al
    Thyroid cancers potentially preventable by reducing overweight and obesity in Australia: A pooled cohort study.
    Int J Cancer. 2022;150:1281-1290.
    PubMed     Abstract available

  6. LIU H, Li G, Sturgis EM, Shete S, et al
    Genetic variants in CYP2B6 and HSD17B12 associated with the risk of squamous cell carcinoma of the head and neck.
    Int J Cancer. 2022 Apr 11. doi: 10.1002/ijc.34023.
    PubMed     Abstract available

  7. GARSET-ZAMANI M, Carlander AF, Jakobsen KK, Friborg J, et al
    Impact of specific high-risk human papillomavirus genotypes on survival in oropharyngeal cancer.
    Int J Cancer. 2022;150:1174-1183.
    PubMed     Abstract available

    March 2022
  8. LONG Z, Wang W, Liu W, Wang F, et al
    Trend of nasopharyngeal carcinoma mortality and years of life lost in China and Its Provinces from 2005 to 2020.
    Int J Cancer. 2022 Mar 14. doi: 10.1002/ijc.33998.
    PubMed     Abstract available

  9. RETTIG EM, Faden DL, Sandhu S, Wong K, et al
    Detection of Circulating Tumor Human Papillomavirus DNA Before Diagnosis of HPV-Positive Head and Neck Cancer.
    Int J Cancer. 2022 Mar 9. doi: 10.1002/ijc.33996.
    PubMed     Abstract available

    February 2022
  10. LIU J, Li J, Lin W, Shao D, et al
    Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): a multicenter, phase 2 study.
    Int J Cancer. 2022 Feb 21. doi: 10.1002/ijc.33976.
    PubMed     Abstract available

  11. WURSTHORN A, Schwager C, Kurth I, Peitzsch C, et al
    High-Complexity cellular barcoding and clonal tracing reveals stochastic and deterministic parameters of radiation resistance.
    Int J Cancer. 2022;150:663-677.
    PubMed     Abstract available

  12. PATEL KK, Chakravarti P, Chaturvedi P, Dikshit R, et al
    The fifth round of the National Family Health Survey of India 2019 to 2021 reported low screening uptake alarming to strengthen the implementation of early detection services of the cervix, breast and oral cancer.
    Int J Cancer. 2022 Feb 6. doi: 10.1002/ijc.33958.

  13. LIU X, Liu P, Chernock RD, Lang Kuhs KA, et al
    Impact of human papillomavirus on the tumor microenvironment in oropharyngeal squamous cell carcinoma.
    Int J Cancer. 2022;150:521-531.
    PubMed     Abstract available

  14. DE VEGT F, Gommers JJJ, Groenewoud H, Siersema PD, et al
    Trends and projections in the incidence of oesophageal cancer in the Netherlands: An age-period-cohort analysis from 1989 to 2041.
    Int J Cancer. 2022;150:420-430.
    PubMed     Abstract available

  15. GHANTOUS Y, Omar M, Broner EC, Agrawal N, et al
    A robust and interpretable gene signature for predicting the lymph node status of primary T1/T2 oral cavity squamous cell carcinoma.
    Int J Cancer. 2022;150:450-460.
    PubMed     Abstract available

    January 2022
  16. VAN DER WATT PJ, Okpara MO, Wishart A, Parker MI, et al
    Nuclear transport proteins are secreted by cancer cells and identified as potential novel cancer biomarkers.
    Int J Cancer. 2022;150:347-361.
    PubMed     Abstract available

  17. GAO P, Cai N, Yang X, Yuan Z, et al
    Association of Helicobacter pylori and gastric atrophy with adenocarcinoma of the esophagogastric junction in Taixing, China.
    Int J Cancer. 2022;150:243-252.
    PubMed     Abstract available

  18. KRENS SD, van Boxtel W, Uijen MJM, Jansman FGA, et al
    Exposure-toxicity relationship of cabozantinib in patients with renal cell cancer and salivary gland cancer.
    Int J Cancer. 2022;150:308-316.
    PubMed     Abstract available

    December 2021
  19. DENEUVE S, Perol O, Dantony E, Guizard AV, et al
    Diverging incidence trends of oral tongue cancer compared to other head and neck cancers in young adults in France.
    Int J Cancer. 2021 Dec 10. doi: 10.1002/ijc.33896.
    PubMed     Abstract available

    November 2021
  20. LASSEN P, Huang SH, Su J, Waldron J, et al
    Treatment outcomes and survival following definitive (chemo) radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts.
    Int J Cancer. 2021 Nov 18. doi: 10.1002/ijc.33876.
    PubMed     Abstract available

    October 2021
  21. TAWK B, Wirkner U, Schwager C, Rein K, et al
    Tumor DNA-Methylome derived Epigenetic Fingerprint Identifies HPV-negative Head and Neck Patients at Risk for Locoregional Recurrence after Postoperative Radiochemotherapy.
    Int J Cancer. 2021 Oct 14. doi: 10.1002/ijc.33842.
    PubMed     Abstract available

    September 2021
  22. DE LA COUR CD, von Buchwald C, Dehlendorff C, Garset-Zamani M, et al
    Low-dose aspirin use and mortality risk in patients with head and neck cancer - a nationwide cohort study of 10,770 patients.
    Int J Cancer. 2021 Sep 18. doi: 10.1002/ijc.33814.
    PubMed     Abstract available

  23. CABASAG CJ, Arnold M, Pineros M, Morgan E, et al
    Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2.
    Int J Cancer. 2021;149:1239-1246.
    PubMed     Abstract available

  24. TANAKA H, Suzuki M, Takemoto N, Fukusumi T, et al
    Performance of Oral HPV DNA, Oral HPV mRNA, and Circulating Tumor HPV DNA in the Detection of HPV-Related Oropharyngeal Cancer and Cancer of Unknown Primary.
    Int J Cancer. 2021 Sep 6. doi: 10.1002/ijc.33798.
    PubMed     Abstract available

  25. NABHAN F, Dedhia PH, Ringel MD
    Thyroid cancer, recent advances in diagnosis and therapy.
    Int J Cancer. 2021;149:984-992.
    PubMed     Abstract available

    July 2021
  26. NAUTA IH, Heideman DAM, Brink A, van der Steen B, et al
    The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma.
    Int J Cancer. 2021;149:420-430.
    PubMed     Abstract available

    June 2021
  27. BUDUKH A, Dikshit R, Chaturvedi P
    Outcome of the randomized control screening trials on Oral, Cervix and Breast Cancer from India and way forward in COVID-19 pandemic situation.
    Int J Cancer. 2021 Jun 21. doi: 10.1002/ijc.33712.

  28. TRUONG T, Lesueur F, Sugier PE, Guibon J, et al
    Multiethnic genome-wide association study of differentiated thyroid cancer in the EPITHYR consortium.
    Int J Cancer. 2021;148:2935-2946.
    PubMed     Abstract available

    May 2021
  29. HOFHEINZ RD, Hegewisch-Becker S, Kunzmann V, Thuss-Patience P, et al
    Trastuzumab in combination with 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) as perioperative treatment for patients with HER2-positive locally advanced esophagogastric adenocarcinoma: A phase II trial of the AIO Gastric Cancer Study G
    Int J Cancer. 2021 May 21. doi: 10.1002/ijc.33696.
    PubMed     Abstract available

  30. NARH CT, Dzamalala CP, Mmbaga BT, Menya D, et al
    Geophagia and risk of squamous cell esophageal cancer in the African esophageal cancer corridor - Findings from the ESCCAPE multi-country case-control studies.
    Int J Cancer. 2021 May 18. doi: 10.1002/ijc.33688.
    PubMed     Abstract available

    April 2021
  31. BUSSMANN L, Hoffer K, von Bargen CM, Droste C, et al
    Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src-family kinases as prognostic markers and potential targets.
    Int J Cancer. 2021 Apr 22. doi: 10.1002/ijc.33606.
    PubMed     Abstract available

  32. LIU C, Song K, Hu Q, Hu C, et al
    Having gastroesophageal cancer is associated with increased risk of severe COVID-19-related events in patients with digestive tract cancer: A multicenter, retrospective, cohort study.
    Int J Cancer. 2021;148:1789-1793.

  33. SHI Z, Wei J, Na R, Resurreccion WK, et al
    Cystic fibrosis F508del carriers and cancer risk: Results from the UK Biobank.
    Int J Cancer. 2021;148:1658-1664.
    PubMed     Abstract available

  34. LING Z, Cheng B, Tao X
    Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities.
    Int J Cancer. 2021;148:1548-1561.
    PubMed     Abstract available

    March 2021
  35. NARUSAKA T, Ohara T, Noma K, Nishiwaki N, et al
    Nanog is a promising chemo-resistant stemness marker and therapeutic target by iron chelators for esophageal cancer.
    Int J Cancer. 2021 Mar 4. doi: 10.1002/ijc.33544.
    PubMed     Abstract available

  36. MIDDLETON DRS, Mmbaga BT, O'Donovan M, Abedi-Ardekani B, et al
    Minimally invasive esophageal sponge cytology sampling is feasible in a Tanzanian community setting.
    Int J Cancer. 2021;148:1208-1218.
    PubMed     Abstract available

  37. IMAMURA Y, Toihata T, Haraguchi I, Ogata Y, et al
    Immunogenic characteristics of microsatellite instability-low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses.
    Int J Cancer. 2021;148:1260-1275.
    PubMed     Abstract available

  38. LIU Y, Lai F, Long J, Peng S, et al
    Screening and the epidemic of thyroid cancer in China: An analysis of national representative inpatient and commercial insurance databases.
    Int J Cancer. 2021;148:1106-1114.
    PubMed     Abstract available

    February 2021
  39. PARAD MT, Fararouei M, Mirahmadizadeh AR, Afrashteh S, et al
    Thyroid cancer and its associated factors: a population based case-control study.
    Int J Cancer. 2021 Feb 26. doi: 10.1002/ijc.33537.
    PubMed     Abstract available

  40. XIE SH, Ness-Jensen E, Langseth H, Gislefoss RE, et al
    Prediagnostic circulating levels of sex hormones and survival in esophageal adenocarcinoma.
    Int J Cancer. 2021;148:905-913.
    PubMed     Abstract available

    January 2021
  41. TAKADA K, Aizawa Y, Sano D, Okuda R, et al
    Establishment of PDX-derived salivary adenoid cystic carcinoma cell lines using organoid culture method.
    Int J Cancer. 2021;148:193-202.
    PubMed     Abstract available

    December 2020
  42. VON WITZLEBEN A, Fehn A, Grages A, EziC J, et al
    Prospective longitudinal study of immune checkpoint molecule (ICM) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma (HNSCC).
    Int J Cancer. 2020 Dec 17. doi: 10.1002/ijc.33446.
    PubMed     Abstract available

  43. GETZ KR, Bellile E, Zarins KR, Rullman C, et al
    Statin Use and Head and Neck Squamous Cell Carcinoma Outcomes.
    Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33441.
    PubMed     Abstract available

  44. MMBAGA BT, Mwasamwaja A, Mushi G, Mremi A, et al
    Missing and Decayed Teeth, Oral Hygiene and Dental Staining in relation to Esophageal Cancer Risk: ESCCAPE case-control study in Kilimanjaro Tanzania.
    Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33433.
    PubMed     Abstract available

  45. CHOI J, Jia G, Wen W, Long J, et al
    Evaluating polygenic risk scores in assessing risk of nine solid and hematologic cancers in European descendants.
    Int J Cancer. 2020;147:3416-3423.
    PubMed     Abstract available

  46. ANTONSSON A, de Souza M, Wood ZC, Carroll A, et al
    Natural history of oral HPV infection - longitudinal analyses in prospective cohorts from Australia.
    Int J Cancer. 2020 Dec 15. doi: 10.1002/ijc.33442.
    PubMed     Abstract available

  47. CHEN GH, Liu Z, Ji MF, Pfeiffer RM, et al
    Prospective Assessment of a Nasopharyngeal Carcinoma Risk Score in a Population Undergoing Screening.
    Int J Cancer. 2020 Dec 7. doi: 10.1002/ijc.33424.
    PubMed     Abstract available

  48. YANG CS, Chen XL
    Research on esophageal cancer: with personal perspectives from studies in China and Kenya.
    Int J Cancer. 2020 Dec 3. doi: 10.1002/ijc.33421.
    PubMed     Abstract available

    November 2020
  49. SONG L, Zhang S, Yu S, Ma F, et al
    Cellular heterogeneity landscape in laryngeal squamous cell carcinoma.
    Int J Cancer. 2020;147:2879-2890.
    PubMed     Abstract available

  50. CAPPAGLI V, Caldarella A, Manneschi G, Piaggi P, et al
    Nonthyroidal second primary malignancies in differentiated thyroid cancer patients: Is the incidence increased comparing to the general population and could it be a radioiodine therapy consequence?
    Int J Cancer. 2020;147:2838-2846.
    PubMed     Abstract available

  51. GARCIA RODRIGUEZ LA, Soriano-Gabarro M, Vora P, Cea Soriano L, et al
    Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.
    Int J Cancer. 2020;147:2394-2404.
    PubMed     Abstract available

  52. JUWEID ME, Tulchinsky M, Mismar A, Momani M, et al
    Contemporary considerations in adjuvant radioiodine treatment of adults with differentiated thyroid cancer.
    Int J Cancer. 2020;147:2345-2354.
    PubMed     Abstract available

    October 2020
    Esophageal sponge sampling: a promising approach for early detection of esophageal cancer in Africa's high-incidence region.
    Int J Cancer. 2020 Oct 31. doi: 10.1002/ijc.33372.

  54. BASILI T, Dopeso H, Kim SH, Ferrando L, et al
    Oncogenic properties and signaling basis of the PAX8-GLIS3 fusion gene.
    Int J Cancer. 2020;147:2253-2264.
    PubMed     Abstract available

  55. YUAN S, Kar S, Vithayathil M, Carter P, et al
    Causal associations of thyroid function and dysfunction with overall, breast and thyroid cancer: A two-sample Mendelian randomization study.
    Int J Cancer. 2020;147:1895-1903.
    PubMed     Abstract available

    September 2020
  56. ZHANG J, Luo X, Huang Q, Huang Y, et al
    Clinicopathological and Prognostic Features of Nasopharyngeal Carcinoma in Children and Adolescents: A Retrospective Study of 196 Cases in South China.
    Int J Cancer. 2020 Sep 15. doi: 10.1002/ijc.33293.
    PubMed     Abstract available

  57. BUCKLE GC, Mahapatra R, Mwachiro M, Akoko L, et al
    Optimal management of esophageal cancer in Africa: A systemic review of treatment strategies.
    Int J Cancer. 2020 Sep 15. doi: 10.1002/ijc.33299.
    PubMed     Abstract available

  58. PLATH M, Gass J, Hlevnjak M, Li Q, et al
    Unraveling most abundant mutational signatures in head and neck cancer.
    Int J Cancer. 2020 Sep 15. doi: 10.1002/ijc.33297.
    PubMed     Abstract available

  59. SIRRI E, Kieschke J, Vohmann C, Katalinic A, et al
    Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study.
    Int J Cancer. 2020;147:1548-1558.
    PubMed     Abstract available

  60. MOHEBBI E, Hadji M, Rashidian H, Rezaianzadeh A, et al
    Opium Use and the Risk of Head and Neck Squamous Cell Carcinoma.
    Int J Cancer. 2020 Sep 7. doi: 10.1002/ijc.33289.
    PubMed     Abstract available

  61. TANAKA H, Takemoto N, Horie M, Takai E, et al
    Circulating Tumor HPV DNA Complements PET-CT in Guiding Management after Radiotherapy in HPV-Related Squamous Cell Carcinoma of the Head and Neck.
    Int J Cancer. 2020 Sep 7. doi: 10.1002/ijc.33287.
    PubMed     Abstract available

    August 2020
  62. BOSETTI C, Carioli G, Santucci C, Bertuccio P, et al
    Global trends in oral and pharyngeal cancer incidence and mortality.
    Int J Cancer. 2020;147:1040-1049.
    PubMed     Abstract available

  63. WALPOLE E, Dunn N, Youl P, Harden H, et al
    Nonbreast cancer incidence, treatment received and outcomes: Are there differences in breast screening attendees versus nonattendees?
    Int J Cancer. 2020;147:856-865.
    PubMed     Abstract available

  64. DALMARTELLO M, Decarli A, Ferraroni M, Bravi F, et al
    Dietary patterns and oral and pharyngeal cancer using latent class analysis.
    Int J Cancer. 2020;147:719-727.
    PubMed     Abstract available

    July 2020
  65. CHEN W, Li H, Ren J, Zheng R, et al
    Selection of high-risk individuals for esophageal cancer screening: A prediction model of esophageal squamous cell carcinoma based on a multicenter screening cohort in rural China.
    Int J Cancer. 2020 Jul 14. doi: 10.1002/ijc.33208.
    PubMed     Abstract available

  66. HOLMBERG D, Ness-Jensen E, Mattsson F, Lagergren J, et al
    Endoscopy for gastroesophageal reflux disease and survival in esophageal adenocarcinoma.
    Int J Cancer. 2020;147:93-99.
    PubMed     Abstract available

    June 2020
  67. HU Y, Zhang X, Wang O, Bi Y, et al
    The genomic profile of parathyroid carcinoma based on whole-genome sequencing.
    Int J Cancer. 2020 Jun 23. doi: 10.1002/ijc.33166.
    PubMed     Abstract available

  68. SINGHAVI HR, Chakrabarti S, Singh A, Mair M, et al
    Comparison of the seventh and eighth editions American Joint Committee Cancer classification system in oral cavity squamous cell cancers.
    Int J Cancer. 2020;146:3379-3384.
    PubMed     Abstract available

  69. FACOMPRE ND, Rajagopalan P, Sahu V, Pearson AT, et al
    Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models.
    Int J Cancer. 2020 Jun 1. doi: 10.1002/ijc.33125.
    PubMed     Abstract available

  70. DEMOURY C, De Schutter H, Faes C, Carbonnelle S, et al
    Thyroid cancer incidence near nuclear sites in Belgium: An ecological study at small geographical level.
    Int J Cancer. 2020;146:3034-3043.
    PubMed     Abstract available

  71. VAN BOXTEL W, Verhaegh GW, van Engen-van Grunsven IA, van Strijp D, et al
    Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients.
    Int J Cancer. 2020;146:3196-3206.
    PubMed     Abstract available

    May 2020
  72. MESSERSCHMIDT C, Obermayer B, Klinghammer K, Ochsenreither S, et al
    Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.
    Int J Cancer. 2020 May 29. doi: 10.1002/ijc.33123.
    PubMed     Abstract available

  73. TAY JK, Siow CH, Goh HL, Lim CM, et al
    A comparison of EBV serology and serum cell-free DNA as screening tools for nasopharyngeal cancer: Results of the Singapore NPC screening cohort.
    Int J Cancer. 2020;146:2923-2931.
    PubMed     Abstract available

  74. HOLLECZEK B, Schottker B, Brenner H
    Helicobacter pylori infection, chronic atrophic gastritis and risk of stomach and esophagus cancer: Results from the prospective population-based ESTHER cohort study.
    Int J Cancer. 2020;146:2773-2783.
    PubMed     Abstract available

    April 2020
  75. REN J, Xu W, Su J, Ren X, et al
    Multiple imputation and clinico-serological models to predict human papillomavirus status in oropharyngeal carcinoma: An alternative when tissue is unavailable.
    Int J Cancer. 2020;146:2166-2174.
    PubMed     Abstract available

  76. SIMON J, Schroeder L, Ingarfield K, Diehl S, et al
    Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.
    Int J Cancer. 2020 Apr 12. doi: 10.1002/ijc.33006.
    PubMed     Abstract available

    February 2020
  77. ZHOU C, Diao P, Wu Y, Wei Z, et al
    Development and validation of a seven-immune-feature-based prognostic score for oral squamous cell carcinoma after curative resection.
    Int J Cancer. 2020;146:1152-1163.
    PubMed     Abstract available

    January 2020
  78. NAKAGAWA T, Matsusaka K, Misawa K, Ota S, et al
    Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes.
    Int J Cancer. 2020 Jan 30. doi: 10.1002/ijc.32890.
    PubMed     Abstract available

    November 2019
  79. VEYER D, Wack M, Mandavit M, Garrigou S, et al
    HPV circulating tumoral DNA quantification by droplet-based digital PCR: a promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
    Int J Cancer. 2019 Nov 22. doi: 10.1002/ijc.32804.

  80. LEHTINEN M, Apter D, Eriksson T, Harjula K, et al
    Effectiveness of the AS04-adjuvanted HPV-16/18 vaccine in reducing oropharyngeal HPV infections in young females - results from a community-randomized trial.
    Int J Cancer. 2019 Nov 17. doi: 10.1002/ijc.32791.
    PubMed     Abstract available

    October 2019
  81. BETTAMPADI D, Villa LL, Lazcano Ponce E, Salmeron J, et al
    Oral Human Papillomavirus Prevalence and Type Distribution by Country (Brazil, Mexico and the United States) and Age among HPV Infection in Men (HIM) Study Participants.
    Int J Cancer. 2019 Oct 3. doi: 10.1002/ijc.32713.
    PubMed     Abstract available

    July 2019
  82. PRITCHETT NR, Maziarz M, Shu XO, Kamangar F, et al
    Serum ghrelin and esophageal and gastric cancer in two cohorts in China.
    Int J Cancer. 2019 Jul 27. doi: 10.1002/ijc.32597.
    PubMed     Abstract available

  83. GIULIANO AR, Nedjai B, Lorincz AT, Schell MJ, et al
    Methylation Of Hpv 16 And Epb41l3 In Oral Gargles: Associations With Oropharyngeal Cancer Detection And Tumor Characteristics.
    Int J Cancer. 2019 Jul 15. doi: 10.1002/ijc.32570.
    PubMed     Abstract available

  84. DOK R, Bamps M, Glorieux M, Zhao P, et al
    Radiosensitization approaches for HPV-positive and HPV-negative head and neck squamous carcinomas.
    Int J Cancer. 2019 Jul 8. doi: 10.1002/ijc.32558.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.